دورية أكاديمية
أعرض في EDS

The association of menopause with cardiometabolic disease risk factors in low- and middle-income countries: a systematic review and meta-analyses.

التفاصيل البيبلوغرافية
العنوان: The association of menopause with cardiometabolic disease risk factors in low- and middle-income countries: a systematic review and meta-analyses.
المؤلفون: Chikwati RP, Chikowore T, Mahyoodeen NG; Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Jaff NG; From the Department of Chemical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., George JA, Crowther NJ
المصدر: Menopause (New York, N.Y.) [Menopause] 2024 Jan 01; Vol. 31 (1), pp. 77-85. Date of Electronic Publication: 2023 Dec 18.
نوع المنشور: Meta-Analysis; Systematic Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott-Raven Publishers Country of Publication: United States NLM ID: 9433353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0374 (Electronic) Linking ISSN: 10723714 NLM ISO Abbreviation: Menopause Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott-Raven Publishers
Original Publication: New York, NY : Raven Press, c1994-
مواضيع طبية MeSH: Metabolic Syndrome*/epidemiology , Cardiovascular Diseases*/epidemiology, Female ; Humans ; Developing Countries ; Premenopause ; Risk Factors
مستخلص: Importance: Menopause is an integral part of women's health, and studies in high-income countries have shown an increase in cardiometabolic disease (CMD) risk factors in postmenopausal compared with premenopausal women. However, to date, no study has combined and assessed such studies across low- and middle-income countries. This would better inform early monitoring and intervention strategies for reducing CMD risk factor levels in midlife women in these regions.
Objective: This study aimed to evaluate evidence from the literature on differences in CMD risk factors between premenopausal and postmenopausal midlife women living in low- and middle-income countries.
Evidence Review: A systematic review with meta-analysis of original articles of all study designs from the databases PubMed, PubMed Central, Scopus, and ISI Web of Science was conducted from conception until April 24, 2023. Studies that met the inclusion criteria were included in the analysis. Quality assessment of the articles was done using the Newcastle-Ottawa Scale, adapted for each study design. The study protocol was registered with the International Prospective Register of Systematic Reviews and adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis. For the meta-analysis, fixed-effects models were used to pool the odds ratios (OR), as measures of association.
Findings: Our search identified 4,849 relevant articles: 44 for the systematic review and 16 for the meta-analysis, in accordance with our inclusion criteria. Compared with premenopausal women, the postmenopausal stage was associated with metabolic syndrome (OR, 1.18 [95% CI, 1.11-1.27]), high waist-to-hip ratio (OR, 1.22 [95% CI, 1.12-1.32]), hypertension (OR, 1.10 [95% CI, 1.04-1.16]), elevated triglycerides (OR, 1.16 [95% CI, 1.11-1.21]), and elevated plasma glucose (OR, 1.21 [95% CI, 1.15-1.28]).
Conclusions and Relevance: This study confirmed that CMD risk factors are present at higher levels in postmenopausal than premenopausal women. This demonstrates an urgent need for public health policies that focus on early monitoring and interventions targeted at reducing CMD risk and related adverse outcomes in midlife women in these nations.
Competing Interests: Financial disclosure/conflicts of interest: Nicole G. Jaff receives funding from the International Menopause Society and the South African Menopause Society. Tinashe Chikowore is an international training fellow supported by the Wellcome Trust grant (214205/Z/18/Z). The other authors have nothing to disclose.
(Copyright © 2023 by The Menopause Society.)
References: Lipids Health Dis. 2019 Jul 17;18(1):155. (PMID: 31315681)
Menopause. 2021 Feb 22;28(5):546-553. (PMID: 33625107)
Maturitas. 2007 Oct 20;58(2):150-5. (PMID: 17768019)
Arq Bras Cardiol. 2010 Sep;95(3):339-45. (PMID: 20658092)
Maturitas. 2015 Mar;80(3):282-7. (PMID: 25563399)
J Clin Endocrinol Metab. 2007 Mar;92(3):895-901. (PMID: 17192296)
BMC Endocr Disord. 2019 Oct 11;19(1):98. (PMID: 31601203)
Maturitas. 2020 May;135:74-79. (PMID: 32252968)
J Clin Lipidol. 2015 Jul-Aug;9(4):553-8. (PMID: 26228673)
Braz J Infect Dis. 2017 May - Jun;21(3):263-269. (PMID: 28284656)
ARYA Atheroscler. 2013 Nov;9(6):332-6. (PMID: 24575135)
Menopause. 2019 Mar;26(3):325-330. (PMID: 30130291)
J Midlife Health. 2012 Jan;3(1):24-30. (PMID: 22923976)
Menopause. 2018 Oct;25(10):1155-1164. (PMID: 29787477)
J Women Aging. 2022 Jan-Feb;34(1):65-78. (PMID: 32594888)
Sci Rep. 2021 Jul 20;11(1):14750. (PMID: 34285301)
Sci Rep. 2015 Jan 28;5:8076. (PMID: 25627797)
Circulation. 1996 Jul 1;94(1):61-6. (PMID: 8964119)
Climacteric. 2014 Aug;17(4):442-8. (PMID: 24156784)
Biomed Res Int. 2020 Apr 29;2020:2168381. (PMID: 32420328)
Int J Epidemiol. 1990 Jun;19(2):297-302. (PMID: 2376439)
Menopause. 2012 Mar;19(3):361-7. (PMID: 21971210)
Fertil Steril. 2019 Apr;111(4):780-786. (PMID: 30929733)
Menopause. 2019 Jan;26(1):39-44. (PMID: 29975281)
Arq Bras Cardiol. 2022 May;118(5):905-913. (PMID: 35613189)
Public Health Nutr. 2013 Apr;16(4):582-90. (PMID: 22883486)
Menopause. 2001 Jul-Aug;8(4):239-44. (PMID: 11449080)
Hum Reprod. 2014 Nov;29(11):2522-9. (PMID: 25267788)
JAMA. 2006 Mar 15;295(11):1288-99. (PMID: 16537739)
Arch Iran Med. 2013 Mar;16(3):161-6. (PMID: 23432168)
Diabetol Metab Syndr. 2010 Oct 05;2:59. (PMID: 20923542)
Metabolism. 2015 Sep;64(9):1031-41. (PMID: 26031506)
Am J Epidemiol. 2001 Sep 15;154(6):489-94. (PMID: 11549553)
Int J Epidemiol. 2014 Oct;43(5):1542-62. (PMID: 24771324)
PLoS Med. 2021 Mar 29;18(3):e1003583. (PMID: 33780438)
Endocr Rev. 2013 Jun;34(3):309-38. (PMID: 23460719)
Arch Intern Med. 2008 Jul 28;168(14):1568-75. (PMID: 18663170)
Climacteric. 2014 Apr;17(2):164-72. (PMID: 23895384)
Climacteric. 1999 Sep;2(3):205-11. (PMID: 11910598)
Physiol Rev. 2013 Jan;93(1):359-404. (PMID: 23303913)
J Lipid Res. 2019 Oct;60(10):1710-1719. (PMID: 30097511)
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73. (PMID: 20082925)
Atherosclerosis. 2008 Feb;196(2):590-7. (PMID: 17675039)
Cardiovasc J Afr. 2008 Jul-Aug;19(4):183-7. (PMID: 18776958)
Climacteric. 2007 Apr;10(2):164-70. (PMID: 17453865)
BMC Res Notes. 2013 Apr 18;6:157. (PMID: 23597398)
Anthropol Anz. 2010;68(1):1-10. (PMID: 20954451)
Biomed Res Int. 2014;2014:457131. (PMID: 24800228)
Maturitas. 2019 Dec;130:32-37. (PMID: 31706433)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
Menopause. 2012 Sep;19(9):1022-8. (PMID: 22549168)
Maturitas. 2012 Jun;72(2):132-8. (PMID: 22445219)
Climacteric. 2013 Oct;16(5):561-7. (PMID: 23157491)
BMC Endocr Disord. 2020 Jun 22;20(1):91. (PMID: 32571278)
Gynecol Endocrinol. 2014 Aug;30(8):573-6. (PMID: 24720345)
Clin Exp Hypertens. 2016;38(4):370-4. (PMID: 27149156)
Annu Rev Public Health. 2017 Mar 20;38:145-164. (PMID: 28068485)
Nutr Metab (Lond). 2022 Feb 5;19(1):7. (PMID: 35123520)
Menopause. 2009 Mar-Apr;16(2):257-64. (PMID: 18971793)
Menopause. 2006 Mar-Apr;13(2):280-5. (PMID: 16645541)
Gynecol Endocrinol. 2018 Aug;34(8):670-674. (PMID: 29463203)
Adv Ther. 2007 Nov-Dec;24(6):1210-20. (PMID: 18165203)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; 214205 United Kingdom WT_ Wellcome Trust
تواريخ الأحداث: Date Created: 20231219 Date Completed: 20240101 Latest Revision: 20240319
رمز التحديث: 20240320
مُعرف محوري في PubMed: PMC7615510
DOI: 10.1097/GME.0000000000002292
PMID: 38113417
قاعدة البيانات: MEDLINE
الوصف
تدمد:1530-0374
DOI:10.1097/GME.0000000000002292